Tempus ai company profile

Tempus AI Inc. is a technology company that is a leader in the field of AI-enabled precision medicine. Here is a detailed company profile:

1. Overview: Tempus AI Inc. is a healthcare technology company that collects and analyzes molecular, clinical, and genomic data through the use of artificial intelligence technology. It is focused on accelerating and transforming personalized patient care by leveraging AI to improve diagnostics, treatment effectiveness, and clinical trial identification.
2. Services: The company offers a range of services including genomic sequencing, clinical data structuring, image recognition, biological modeling, and TIME Trial technology platform. It also provides clinical decision support services, analytical tools for data access and interpretation, and data solutions for researchers.
3. Collaborations: Tempus partners with various institutes and hospitals and serves providers, payers, researchers, and life sciences companies. It has collaborations with more than 65% of all Academic Medical Centers in the US and is connected to more than 50% of oncologists in the US through sequencing, clinical trial matching, and research-enabled partnerships.
4. Innovation: Tempus has been at the forefront of innovation in the field of precision medicine. It has received FDA Breakthrough Device Designation for its HLA-LOH Companion Diagnostic Test and has launched a standalone RNA Sequencing Test, Tempus xR, which reports clinically relevant fusions for more than 100 targeted genes.
5. Financials: Tempus AI Inc. has a strong financial position with a revenue of $531.8M in 2022, a significant increase from the previous year, and a net profit margin of 55.5% in 2022. The company has also received significant investment, with more than $200 million in biopharma partnerships and a joint venture with SoftBank Group to examine personal medical data with artificial intelligence.
6. History: Tempus was founded in 2015 by Eric Lefkofsky, in response to his wife's breast cancer diagnosis. Since then, it has expanded its platform to multiple areas of healthcare, including oncology, neuropsychiatry, cardiology, infectious disease, and radiology.

In conclusion, Tempus AI Inc. is a leading technology company in the field of AI-enabled precision medicine, with a strong focus on innovation, collaboration, and financial growth. Its services and products are designed to improve patient care, drug development, and clinical trial identification, making it a key player in the healthcare technology sector.